Can I take Mitotane alone for adrenocortical cancer?

Mitotane (Mitotane) is currently a specialty treatment drug that is widely used in adrenocortical cancer (ACC; adrenal cancer ) internationally. Whether its use as a single drug is feasible has always been one of the core issues that patients and doctors pay attention to. Mitotane is a steroid metabolism-related drug. Its main mechanism of action is not to directly "kill tumors", but to achieve long-term disease control by regulating the function of adrenocortical cells and affecting hormone pathways. Therefore, "whether it can be used alone" depends on the patient's stage of disease, the surgery and the tumor's response pattern to the drug.

In the treatment pathway of adrenocortical cancer, mitotane is often used as the core drug for postoperative adjuvant therapy. If the patient has undergone complete resection and there is no immediate indication for chemotherapy, mitotane single-agent maintenance therapy is one of the common options. It is considered a"systemic long-term management tool" to delay relapse and control hormone-related symptoms. The advantage of this type of single-drug regimen is that it is highly targeted, has relatively controllable side effects, and can continuously and stably reduce tumor activity.

However, for patients with high tumor burden, rapid disease progression, or obvious metastasis, overseas guidelines often recommend the use of mitotane in combination with chemotherapy. Combination regimens are more used to pursue stronger tumor control, and the hormone inhibitory effect of mitotane itself can complement chemotherapy. Therefore, mitotane alone is not suitable for everyone and depends on the biological behavior of the tumor and the overall treatment strategy.

It takes a long time to establish the steady-state concentration of mitotane in the body, and the drug is widely distributed. Therefore, monotherapy requires more emphasis on long-term regular administration and concentration monitoring. In terms of symptom control, many patients can also achieve improvements in symptoms related to excess adrenal hormones, such as fatigue, weight changes, or metabolic abnormalities, using a single drug.

Reference materials:https://go.drugbank.com/drugs/DB00648